The director of the German laboratory BioNTech, which is working with the American Pfizer on a vaccine against Covid-19, estimated Thursday “possible“its authorization and distribution by the end of the year in the United States or the European Union.
“There is a chance that we can still obtain the authorization this year in the United States or in Europe or in both regions“, said Ugur Sahin in an interview with AFP, specifying that the authorization request will be filed on Friday at the US Medicines Agency (FDA). “We may be able to deliver vaccines in December”, he adds.
The vaccine developed by the Pfizer / BioNTech alliance is 95% safe and effective in preventing Covid-19, according to comprehensive results from their clinical trial, a level similar to Moderna’s and which increases the chances that at least one can begin to be injected into the arms of Americans before the end of the year.
At home in Belgium, the Minister of Health Franck Vandenbroucke, has indicated that “deliveries could be possible at the beginning of January”